Quickly Generate High-Diversity, High-
Quality Molecules Inspired by the Human
Repertoire
Best-In-Class Synthetic Libraries Powered by Twist Technology
We are writing the future of biologics discovery with a best-in-class platform, our Library of Libraries, for hard-to-drug targets. Our collection of 17+ off-the-shelf libraries enables multiple pathways of discovery for your drug target of interest. We use our precision DNA synthesis technology to focus explicitly on the sequence space that will most benefit you and remove sequences associated with downstream developability and manufacturing liabilities.
浏览我们的文库集合
Quickly Generate High-Diversity, High-
Quality Molecules Inspired by the Human
Repertoire
Best-In-Class Synthetic Libraries Powered by Twist Technology
We are writing the future of biologics discovery with a best-in-class platform, our Library of Libraries, for hard-to-drug targets. Our collection of 17+ off-the-shelf libraries enables multiple pathways of discovery for your drug target of interest. We use our precision DNA synthesis technology to focus explicitly on the sequence space that will most benefit you and remove sequences associated with downstream developability and manufacturing liabilities.
浏览我们的文库集合
Uncover Hits Against Virtually Any Target
拓展发现机会
我们预先构建的、经过验证的噬菌体展示文库是使用我们精确的 DNA 编写技术建立的，支持去除可能导致下游生产不利的基序，并只聚焦适用的序列空间。Twist Bioscience has designed multiple general, naïve, and target-focused libraries with diversities of 1010, giving you a multifaceted approach to your next discovery project.
Fast Antibody Discovery
Our collection of off-the-shelf libraries enables you to quickly identify high-quality leads against your target of interest using multiple strategies in only a few months. Libraries are available in various VHH, Fab, and scFv formats. These libraries can be leveraged to develop monoclonal antibodies, bi- or multi-specifics, and chimeric antigen receptors (CARs) for CAR-T cell therapy.
A Proven Discovery Engine
Internal discovery efforts using the library of libraries have led to the generation and optimization of lead antibody agonists, antagonists, and binders, with robust pre-clinical data packages. Our fully-humanized antibodies and VHH nanobodies are available for licensing. They make it possible to drug high-value targets in broad therapeutic areas, including immuno-oncology, oncology, metabolic diseases, and more.
Uncover Hits Against Virtually Any Target
拓展发现机会
我们预先构建的、经过验证的噬菌体展示文库是使用我们精确的 DNA 编写技术建立的，支持去除可能导致下游生产不利的基序，并只聚焦适用的序列空间。Twist Bioscience has designed multiple general, naïve, and target-focused libraries with diversities of 1010, giving you a multifaceted approach to your next discovery project.
Fast Antibody Discovery
Our collection of off-the-shelf libraries enables you to quickly identify high-quality leads against your target of interest using multiple strategies in only a few months. Libraries are available in various VHH, Fab, and scFv formats. These libraries can be leveraged to develop monoclonal antibodies, bi- or multi-specifics, and chimeric antigen receptors (CARs) for CAR-T cell therapy.
A Proven Discovery Engine
Internal discovery efforts using the library of libraries have led to the generation and optimization of lead antibody agonists, antagonists, and binders, with robust pre-clinical data packages. Our fully-humanized antibodies and VHH nanobodies are available for licensing. They make it possible to drug high-value targets in broad therapeutic areas, including immuno-oncology, oncology, metabolic diseases, and more.
产品说明书
网络研讨会
海报
联系我们
我们的抗体专家随时待命，并希望听到更多关于您的发现需求的信息。欢迎挑战性目标！
